When profit and purpose collide: how to navigate it

When profit and purpose collide, the answer is governance strong enough to absorb the conflict without losing the mission.

This is the post where the series turns on itself. For several posts, I have argued that commercial revenue is not a betrayal of nonprofit purpose. Here, I am naming the cases where commercial logic becomes dangerous if you do not properly design for it. That distinction matters, because previous posts haven’t yet answered the hardest question: what do you do when the money is real, the upside is obvious, and the cost to beneficiaries is also real?

When trust becomes the price of partnership

The first conflict is blunt: a corporate partner asks for beneficiary data as the price of partnership. Nonprofits routinely collect sensitive information on beneficiaries, staff, and donors, and privacy is central to trust. The Council of Nonprofits is direct: organizations should collect only what they need and should inform the people they serve about how that data will be used, stored, and protected [1].

That is the line. If a partner wants more data than the work requires, the partnership already has a key design flaw, as the commercial deal depends on extracting data that beneficiaries did not knowingly offer for that purpose. You are not closing a revenue gap, but you are converting trust into monetizable inventory.

When your IP works against people it was built for

The second conflict is subtler and just as dangerous: you own intellectual property, but the commercial terms would restrict access in the very markets you exist to serve. Nonprofit IP can and has been licensed, and according to the Public Counsel, can be protected and used as an asset that a nonprofit licenses to further its cause and generate revenue. However, the same guide warns that licenses can be exclusive, may carry geographic limits, and can fail badly if not structured with care [2].

That creates a real test for NGOs working in low-income markets. A license that maximizes royalty income by limiting access where need is greatest is a revenue choice, not a mission choice. You must build access clauses, field-of-use limits, or non-exclusive terms into the deal; if you don’t, you may win money and lose the reason the asset mattered in the first place.

Public health licensing practice has already shown that this is navigable. A BMJ Global Health analysis of access-oriented IP negotiations documents how licensing terms can be deliberately structured to preserve access in low-income markets rather than restrict it [3]. The core principle is the same one I argued in the Kaiser Permanente post [4]: nonprofit status does not prohibit commercial revenue, but it changes where the surplus must go and what governance must protect.

What the contract trains the institution to become

The third conflict is one many senior leaders already know from government work: a fee-for-service contract can reward volume rather than outcomes. Federal contracting rules themselves distinguish among contract types because incentives matter. The Federal Acquisition Regulation (FAR) specifies that the objective is to negotiate a contract type that creates reasonable contractor risk and provides the greatest incentive for efficient and economical performance [5].

In practice, that is the difference between a contract that pays for services delivered and a contract that quietly pressures an organization to do more units, faster, whether or not that is best for the people served. A serious NGO does not accept a contract just because the rate is good, but it asks what the contract will train the institution to become.

When the revenue line eats the mission

The fourth conflict is slower and easier to miss. An earned revenue line – a social enterprise subsidiary, a consulting practice, a fee-based training program – starts consuming the organization's best talent, most board attention, and largest share of investment. Meanwhile, mission-critical but non-revenue-generating programs quietly lose resources.

This is institutional drift. No single decision looks wrong, because each reallocation is rational on its own: the sales team is good, the margins are strong, and the board likes the revenue stream. But then, with time, the programs that cannot invoice begin to look expendable, and the organization reorganizes itself around what earns money rather than what the mission requires.

The research on social enterprises is obvious: mission drift is a governance problem. It emerges when organizations combine social and commercial activities and fail to prioritize competing objectives [6]. Cornforth frames the challenge as steering a narrow channel between mission drift and outright failure, one that requires deliberate governance choices rather than goodwill [7].

What governance looks like when it works

The answer is a designed system that prioritizes the mission over revenue.

The clearest proof is the Medicines Patent Pool (MPP), founded by Unitaid in 2010, which exists to solve the exact tension the licensing section above describes: how do you allow commercial production of patented medicines without choking access in the countries that need them most? The answer is in the license terms themselves. MPP licenses are non-exclusive, carry low or zero royalty rates, and define geographic scope using the World Bank's classification of low- and middle-income countries [8]. The terms do not require patent holders to abandon their commercial interests, but they structure those interests; they write access protection into the contract before the first generic manufacturer begins production.  

The same logic applies to every tension this post has named. A data-sharing agreement that specifies what beneficiary information a corporate partner can and cannot access, with audit rights and sunset provisions, prevents the contract structure from turning trust into inventory. A board policy that requires mission-impact review before any earned-revenue line exceeds a defined share of total budget is the guardrail that catches institutional drift before it becomes irreversible.

Ebrahim, Battilana, and Mair describe the underlying logic: hybrid organizations are accountable to multiple stakeholders with competing objectives, and mission drift is mitigated only when governing bodies make the social mission an explicit, structural priority rather than an assumed one [9]. That is what a governance system does when it works. It embeds the mission in the terms governing every commercial relationship the organization enters, rather than relying on good intentions.

What financial resilience costs

Building that discipline is expensive. It requires legal review, board sophistication, internal data governance, and a culture willing to turn down money when the terms are wrong. It also requires an honest assessment of whether the organization has the talent and board capacity to manage a hybrid model at all. Some organizations do not, but the answer is redesign.

The strongest commercial organizations know which opportunities they will reject, and that is the price of financial sovereignty.

The series thesis still stands. Avoiding commercial revenue leaves NGOs trapped in the very grant dependency that has made them vulnerable to funding shocks, delayed payments, and donor retreat. But commercial revenue without governance just imports a different kind of fragility. The organizations that will actually sustain this transition are the ones that confront these hard cases before the market does it for them.

Endnotes

1. Council of Nonprofits, "Earning Trust: The Imperative of Data Privacy for Nonprofits" — https://www.councilofnonprofits.org/articles/earning-trust-imperative-data-privacy-nonprofits

2. Public Counsel, "Intellectual Property Licensing Basics for Nonprofits" — https://publiccounsel.org/wp-content/uploads/2021/12/Intellectual-Property-Licensing-Basics-for-Nonprofits-2016.pdf

3. BMJ Global Health, "Negotiating Public-Health Intellectual Property Licensing Agreements to Increase Access to Health Technologies: An Insider's Story" — https://gh.bmj.com/content/bmjgh/8/9/e012964.full.pdf

4. Claudio Tanca, "The Kaiser Permanente Model: What Integrated Medicine Teaches Development Organizations" — https://www.claudiotanca.info/post/the-kaiser-permanente-model-what-integrated-medicine-teaches-development-organizations

5. Federal Acquisition Regulation, Part 16, "Types of Contracts" — https://www.acquisition.gov/far/part-16

6. Ometto, M. Paola, et al., "From Balancing Missions to Mission Drift: The Role of the Institutional Context, Spaces, and Compartmentalization in the Scaling of Social Enterprises," Business & Society (2019) — https://journals.sagepub.com/doi/10.1177/0007650318758329

7. Cornforth, C., "Understanding and combating mission drift in social enterprises" — https://oro.open.ac.uk/39882/1/SEJ%20paper%202013%20revised-final.pdf

8. Athreye, S., et al., "Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool," NBER Working Paper 28545 — https://www.nber.org/system/files/working_papers/w28545/w28545.pdf; see also Medicines Patent Pool — https://medicinespatentpool.org/

9. Ebrahim, Alnoor, Julie Battilana, and Johanna Mair, "The Governance of Social Enterprises: Mission Drift and Accountability Challenges in Hybrid Organizations," Research in Organizational Behavior (2014) — https://www.hbs.edu/faculty/Pages/item.aspx?num=47977